Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Coronavirus- South Africa: SA Ramps Up COVID-19 Inoculation The department will focus on increasing vaccinations in 10 districts that are lagging behind the rest of the country

07/31/2021 | 12:10pm EDT

With the expected arrival of COVID-19 vaccine batches in the coming days, South Africa will soon be able to vaccinate one million people in three days.

Addressing the media on government’s response to the COVID-19 pandemic, acting Minister of Health, Mmamoloko Kubayi, said vaccination is expected to pick up momentum such that 400 000 vaccinations will be administered per day by the end of the week.

"By the time we open for people between the ages of 18 and 34 to be vaccinated from the 1stof September 2021, we will be able to respond to the demand that this cohort will generate," the Minister said on Friday.

This week South Africa expected the number of vaccinated people per day to reach the target of 300000.

"However, due to the constrained vaccine supply this week, the number of vaccinated people per day was around 220 000 which is likely to be the average this week.

"At the present rate of vaccination, we are currently vaccinating one million people in four days. The number of vaccinated people has just surpassed another milestone of seven million," the Minister said.

This week the vaccine supply was constrained, which has negatively affected the rate of vaccination. This as some of the sites ran out of vaccines and people had to be turned away.

"The good news is that we received more vaccines from Johnson & Johnson and more Pfizer vaccines are expected in the coming days."

The Minister has received a Ministerial Advisory Committee (MAC) on vaccine advisory. "This relates to questions being asked about opening up for more vaccine to meet our demand. The advisory focused on Sinovac and AstraZeneca. We will communicate government’s decision in a week’s time."

South Africa is expecting a delivery of about 10 million Johnson & Johnson doses and about 16 million Pfizer doses this quarter.

According to Department of Health Deputy Director-General, Dr Nicholas Crisp, 1 556 100 Pfizer does will arrive on Sunday 1 August for distribution next week.

"[A total of] 5 660 460 Pfizer doses are arriving between 31 July and 3 August and 1 454 900 Johnson & Johnson (J&J) doses are expected to be distributed in the week of 2 August," Crisp said.

This week South Africa administered 7 297 912 doses of vaccines.

"We have been have been reaching our vaccination targets as we have been building up the capacity on the ground on the vaccinations but we are not reaching the most vulnerable sufficiently and that is something that we will focus o [in] the weeks ahead.

"Our target for August is to reach seven million people over the age of 35 but we must ensure that at least a million of those people are people over the age of 60," he said.

Call for men to vaccinate

Crisp has encouraged men to be inoculated, as they have not been showing up in their numbers to vaccination sites.

"We are not managing to reach that many men, specifically in the older age group, above 50 men are not turning up for vaccination and we encourage men to come for vaccination," Crisp said.

The department will focus on increasing vaccinations in 10 districts that are lagging behind the rest of the country.

The J&J vaccine, which originally targeted the public sector essential worker programme, has been placed in the population programme.

"Part of the focus will be ensuring that we get people in the pension pay queues vaccinated, a large number of those are people are over the age of 60," said Crisp.


Distributed by APO Group on behalf of South African Government.

© African Press Organization, source Press Releases

Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON -0.72% 163.17 Delayed Quote.3.68%
PFIZER, INC. -0.84% 43.57 Delayed Quote.19.37%
All news about JOHNSON & JOHNSON
10:54aJOHNSON & JOHNSON : New Phase 3 Data Suggest Positive Effect and Show Similar Safety with ..
PU
04:33aCORONAVIRUS : U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mo..
AQ
09/24CORONAVIRUS : U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mo..
AQ
09/24JOHNSON & JOHNSON : Pennsylvania Jury Reportedly Finds Johnson & Johnson Baby Power Didn't..
MT
09/24CDC Recommends Booster Shots of Pfizer-BioNTech COVID-19 Vaccine for Older Adults, High..
MT
09/24JOHNSON & JOHNSON : United States Supreme Court Declines To Hear Talcum Powder Appeal
AQ
09/22JOHNSON & JOHNSON : Unit Signs Deal for HealthVerity Patient Data Platform
MT
09/22PRO BANKRUPTCY BRIEFING : J&J Beats Injury Lawyers on Talc Bankruptcy; Judge Questions Tal..
DJ
09/21JOHNSON & JOHNSON : Unit Collaborates With Persephone Biosciences On Stool Analysis
MT
09/21Shangula Rages Against West's Vaccine Nationalism
AQ
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 18,9x
Yield 2021 2,55%
Capitalization 430 B 430 B -
EV / Sales 2021 4,57x
EV / Sales 2022 4,36x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 163,17 $
Average target price 185,83 $
Spread / Average Target 13,9%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON3.68%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY34.09%210 037
ABBVIE INC.0.53%189 211